Physician profile
William Seifert
NPI 1225007479
$662.96
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $183.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $229.72 | 2019-2020 | |
| Abbvie INC. | $173.11 | 2019-2020 | |
| Pfizer INC. | $93.49 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $26.73 | 2019-2020 | |
| Allergan, INC. | $24.99 | 2019 | |
| Amgen INC. | $21.20 | 2019 | |
| Hologic Sales and Service, LLC | $17.76 | 2019 | |
| Coopersurgical, INC. | $17.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.05 | 2020 | |
| Exeltis, USA INC. | $15.40 | 2019 | |
| Therapeuticsmd, INC. | $14.65 | 2019 | |
| Novo Nordisk INC | $12.41 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Seifert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.